Bortezomib and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT00030368 · COMPLETED
Trial details
- NCT number
- NCT00030368
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2001-11-01
- Primary completion
- 2009-02-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.